Insider Transactions in Q3 2024 at Hologic Inc (HOLX)
Insider Transaction List (Q3 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 29
2024
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
52,679
-38.53%
|
$4,214,320
$80.56 P/Share
|
Aug 29
2024
|
Karleen Marie Oberton Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,805
+10.7%
|
$1,312,200
$40.91 P/Share
|
Aug 06
2024
|
Brandon Schnittker Div. President, GYN Surgical |
SELL
Open market or private sale
|
Direct |
476
-11.3%
|
$39,508
$83.11 P/Share
|
Aug 01
2024
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,093
-32.71%
|
$412,533
$81.99 P/Share
|
Jul 30
2024
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
44,039
-1.24%
|
$3,567,159
$81.45 P/Share
|
Jul 30
2024
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
44,039
+3.54%
|
$1,145,014
$26.21 P/Share
|
Jul 17
2024
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
3,672
-0.32%
|
$293,760
$80.13 P/Share
|
Jul 17
2024
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,672
+0.32%
|
$95,472
$26.21 P/Share
|
Jul 17
2024
|
Christiana Stamoulis Director |
SELL
Open market or private sale
|
Direct |
9,039
-16.58%
|
$714,081
$79.5 P/Share
|
Jul 17
2024
|
Christiana Stamoulis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,039
+14.22%
|
$235,014
$26.74 P/Share
|